Aptus Pharma has outlined its next phase of growth focused on developing its own manufacturing capabilities, strengthening its Pan-India presence and exploring opportunities in international markets.

The Board of Directors has approved a proposal to raise Rs 44.88 crore through a preferential issue of equity shares to identified investors.